<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="143074">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02102984</url>
  </required_header>
  <id_info>
    <org_study_id>242/13</org_study_id>
    <nct_id>NCT02102984</nct_id>
  </id_info>
  <brief_title>Covered Versus Uncovered Biliary Stents for Biliary Malignancies</brief_title>
  <official_title>Covered Versus Uncovered Metal Stents for Biliary Malignancies - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nuovo Ospedale Civile S.Agostino Estense</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nuovo Ospedale Civile S.Agostino Estense</source>
  <oversight_info>
    <authority>Italy: National Monitoring Centre for Clinical Trials - Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patency duration of covered metal stents as compared with uncovered metal stents in the
      management of malignant strictures of the extra-hepatic biliary tree.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients with malignant strictures of the extra-hepatic biliary tree considered
      unfit for surgical excision Placement of covered or uncovered metal stents in patients with
      and without gallbladder on the basis of a computer-generated randomization list Evaluation
      of clinical outcome, survival, complications, and quality of life. Evaluation of the cost
      and efficacy of the two types of metal stents.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Relief of malignant biliary obstruction</measure>
    <time_frame>six months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Clinical assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cost/effecacy</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>cost and effectiveness of covered versus uncovered biliary stents</description>
  </secondary_outcome>
  <other_outcome>
    <measure>gallbladder in situ</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Acute cholecystitis could affect the clinical outcome of patients when a covered stent is used</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Biliary Tract Cancer</condition>
  <arm_group>
    <arm_group_label>covered stents</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>endoscopic placement of covered biliary stents</description>
  </arm_group>
  <arm_group>
    <arm_group_label>uncovered biliary stents</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>endoscopic placement of uncovered biliary stents</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>covered biliary stents</intervention_name>
    <description>endoscopic placement of covered biliary stents</description>
    <arm_group_label>covered stents</arm_group_label>
    <other_name>Taewoong Medical NITI-S Covered</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>uncovered biliary stents</intervention_name>
    <description>endoscopic placement of uncovered biliary stents</description>
    <arm_group_label>uncovered biliary stents</arm_group_label>
    <other_name>Taewoong Medical NITI-S Uncovered</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients with symptomatic malignant obstruction of the extra-hepatic biliary
             tree

          -  not eligible for surgical intervention

          -  able to provide informed consent

        Exclusion Criteria:

          -  benign biliary obstruction

          -  previous surgery of the biliary tract

          -  life expectancy &lt; 3 months
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rita Conigliaro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Digestive Endoscopy Unit-NOCSAE- Modena</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rita Conigliaro, MD</last_name>
    <phone>+39.059.396.1752</phone>
    <email>r.conigliaro@ausl.mo.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angelo Caruso, MD</last_name>
    <phone>+39.059.396.1752</phone>
    <email>a.caruso@ausl.mo.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NOCSAE - Viale Giardini 1355</name>
      <address>
        <city>Modena</city>
        <zip>41126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angelo Caruso, MD</last_name>
      <phone>+39.059.396.1752</phone>
      <email>a.caruso@ausl.mo.it</email>
    </contact>
    <investigator>
      <last_name>Angelo Caruso, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Isayama H, Nakai Y, Kogure H, Yamamoto N, Koike K. Biliary self-expandable metallic stent for unresectable malignant distal biliary obstruction: which is better: covered or uncovered? Dig Endosc. 2013 May;25 Suppl 2:71-4. doi: 10.1111/den.12078. Review.</citation>
    <PMID>23617653</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 31, 2014</lastchanged_date>
  <firstreceived_date>March 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nuovo Ospedale Civile S.Agostino Estense</investigator_affiliation>
    <investigator_full_name>Rita Conigliaro, MD</investigator_full_name>
    <investigator_title>Chief - Endoscopy Unit</investigator_title>
  </responsible_party>
  <keyword>distal malignancy of the extra-hepatic biliary tract</keyword>
  <keyword>metallic biliary stents</keyword>
  <keyword>covered biliary stents</keyword>
  <keyword>uncovered biliary stents</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Biliary Tract Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
